- Report
- March 2025
- 185 Pages
Global
From €3226EUR$3,545USD£2,766GBP
€3585EUR$3,939USD£3,073GBP
- Report
- October 2024
- 182 Pages
Global
From €3226EUR$3,545USD£2,766GBP
€3585EUR$3,939USD£3,073GBP
- Report
- October 2024
- 196 Pages
Global
From €3226EUR$3,545USD£2,766GBP
€3585EUR$3,939USD£3,073GBP
- Report
- January 2025
- 100 Pages
Global
From €5415EUR$5,950USD£4,642GBP
- Report
- April 2025
- 93 Pages
Global
From €5097EUR$5,600USD£4,369GBP
- Report
- April 2025
- 898 Pages
Global
From €5324EUR$5,850USD£4,564GBP
- Report
- April 2025
- 94 Pages
Global
From €5324EUR$5,850USD£4,564GBP
- Report
- April 2025
- 175 Pages
Global
From €4086EUR$4,490USD£3,503GBP
- Report
- April 2025
- 200 Pages
Global
From €4086EUR$4,490USD£3,503GBP
- Report
- February 2025
- 200 Pages
Global
From €4086EUR$4,490USD£3,503GBP
- Report
- May 2024
- 131 Pages
Global
From €5915EUR$6,499USD£5,071GBP
- Report
- May 2024
- 138 Pages
Global
From €5915EUR$6,499USD£5,071GBP
- Report
- October 2024
- 318 Pages
Global
From €7235EUR$7,950USD£6,203GBP
- Report
- June 2024
- 200 Pages
Global
From €7235EUR$7,950USD£6,203GBP
- Report
- January 2025
- 194 Pages
Global
From €7235EUR$7,950USD£6,203GBP
- Clinical Trials
- December 2024
- 60 Pages
Global
From €1365EUR$1,500USD£1,170GBP
- Clinical Trials
- June 2024
- 80 Pages
Global
From €1820EUR$2,000USD£1,560GBP
- Drug Pipelines
- May 2024
- 60 Pages
Global
From €1365EUR$1,500USD£1,170GBP
- Report
- January 2025
- 250 Pages
Global
From €4550EUR$4,999USD£3,900GBP
- Report
- October 2024
- 200 Pages
Global
From €3413EUR$3,750USD£2,926GBP

Levodopa is a drug used to treat Parkinson's disease, a neurological disorder that affects movement. It is a dopamine precursor, meaning it is converted into dopamine in the brain, which helps to reduce the symptoms of Parkinson's. Levodopa is usually taken in combination with other drugs, such as carbidopa, to increase its effectiveness. It is one of the most commonly prescribed drugs for Parkinson's, and is often the first line of treatment.
Levodopa is a part of the larger Central Nervous System (CNS) drug market, which includes drugs used to treat a variety of neurological disorders. The CNS drug market is highly competitive, with many different companies offering various treatments.
Some of the companies in the Levodopa market include Merck, Novartis, Teva Pharmaceuticals, and Sun Pharmaceuticals. Show Less Read more